3138 results for «3092»
3138 results
Expanding the indications of DCB for complex PCI scenarios
14 May 2024 – From EuroPCR 2024
This session, with the collaboration of various national societies, explores the use of drug-coated balloons (DCBs) in complex PCI scenarios, such as multivessel disease, left main, bifurcations, CTOs, or myocardial infarction. It includes case presentations and discussions on the procedural techniques, patient selection, and lesion preparation...
When and how to treat the side branch in non-left main bifurcations?
14 May 2024 – From EuroPCR 2024
Explore this video session covering essential techniques for handling bifurcations in coronary interventions. Learn to evaluate side branch significance and the need for a second stent, illustrated through three case studies. Discover main vessel stenting for a large side branch, various approaches like T-stenting, TAP, or...
When and how to plug holes in the cathlab
14 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the diagnosis and management of various types of holes and fistulas encountered in the catheterization laboratory. The cases cover a range of scenarios, including large holes in unexpected locations, left ventricle-left atrial appendage fistulas, pulmonary...
Hotline: advances in coronary physiology
14 May 2024 – From EuroPCR 2024
This hotline session explores the latest advancements in coronary physiology and their implications for percutaneous coronary intervention (PCI). Topics covered include the influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI, the prognostic value of myocardial ischemic burden in STEMI...
Fistula aneurysms
14 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the management of fistula aneurysms. The cases cover a range of scenarios, including a rare cause of right ventricular compression, a giant coronary fistula, suspected coronary steal syndrome, and more. Each case is followed by...
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
Treatment strategies in complex coronary
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex coronary intervention cases from the EuroPCR 2024 Clinical Case submissions. The cases cover a range of challenging scenarios, including CTO with left ventricular dysfunction and VT storm, subintimal tracking and re-entry, and the decision between native vessel CTO PCI...
Primary PCI in different situations
14 May 2024 – From EuroPCR 2024
This session, in collaboration with various international cardiology societies, focuses on the management of primary PCI in different challenging situations. It presents three cases: a late-comer STEMI patient requiring unconventional techniques, a STEMI patient with a free-floating thrombus in the left main, and a STEMI patient...
Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes
14 May 2024 – From EuroPCR 2024
Watch this session to learn how to accurately interpret OCT-visualized dissections for an optimized PCI approach using drug-coated balloons (DCB) or drug-eluting stent (DES), to understand the critical role of sufficient and persistent sirolimus content in the vessel wall after using a sirolimus-coated balloon, to get...
A new horizon in IVUS-guided PCI of calcified stenoses with artificial intelligence
15 May 2024 – From EuroPCR 2024
In this session, observe the enhanced user-friendliness of IVUS-guided complex PCI with improved AI algorithms, recognize the importance of combining experience with advanced knowledge of tools and techniques for optimal PCI outcomes in heavily calcified stenoses, and understand how tailoring drug-eluting devices for calcified lesions can...
TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...
Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI
15 May 2024 – From EuroPCR 2024
Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...
Mitral TEER challenges and complications
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, highlighting the challenges and complications associated with mitral transcatheter edge-to-edge repair (TEER) procedures. Attendees will have the opportunity to engage in discussions and learn from the experiences shared by the presenters, covering...
Second generation biolimus drug-coated balloon in clinical practice
15 May 2024 – From EuroPCR 2024
Discover the potential applications of the new biolimus-coated balloon in treating de novo large vessel lesions, explore its effectiveness in addressing ISR based on findings from the BIO ASCEND ISR study, and uncover insights into the safety and feasibility of BA9 DCB in treating small vessel,...
Challenging situations to access the aortic valve - Part 1
15 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that showcase challenging situations in accessing the aortic valve, including cases with severe peripheral arterial disease, tortuous aortic anatomy, and complex comorbidities. The session provides an opportunity to learn from the experiences of experts in navigating these complex scenarios...
Different treatment options for PCI in calcified lesions
15 May 2024 – From EuroPCR 2024
This session showcases various treatment options for percutaneous coronary intervention (PCI) in calcified lesions. Attendees will learn about the use of excimer laser atherectomy, intravascular lithotripsy, and other techniques to effectively manage challenging calcified coronary lesions. The session features case presentations and discussions, providing insights into...
Endovascular treatment for acute chronic heart failure
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex endovascular cases for the treatment of acute chronic heart failure, including the use of 3D printing and virtual reality to close a pulmonary arteriovenous malformation, closure of a post-septal myectomy ventricular septal defect, and catheter-based treatment of a heart...
NSTEMI in patients in post CABG: a challenging combination
15 May 2024 – From EuroPCR 2024
This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...
Innovating techniques for the treatment of coronary artery disease
14 May 2024 – From EuroPCR 2024
This session showcases innovative techniques for the treatment of coronary artery disease, including minimum contrast PCI with guide extension catheter and IVUS co-registration, management of iatrogenic aortic dissection using 3D-hologram and computational fluid dynamics, a novel tunnelling technique for huge coronary bypass graft aneurysms, and a...
Stentless PCI
15 May 2024 – From EuroPCR 2024
This session explores various stentless percutaneous coronary intervention (PCI) strategies, including drug-coated balloon (DCB)-only PCI for chronic total occlusions and de-novo coronary lesions, as well as the use of magnesium resorbable scaffolds. Attendees will learn about the rationale, techniques, and outcomes of these "leave nothing behind"...
